AIDS and Associated Malignancies

  • William J. Harrington
  • Charles Wood
  • C. Wood


Malignancies are a major complication of AIDS. The most frequently diagnosed HIV-associated cancer is Kaposi’s sarcoma (KS) followed by AIDS-related non-Hodgkin lymphoma (ARL). The development of highly active antiretroviral therapy (HAART) has resulted in a marked decrease in the number of cases of KS and to a lesser degree ARL in countries where these drugs are widely available; however, these tumors are increasing in incidence in developing nations and still pose a major threat in severely immunocompromised patients. AIDS-related KS and ARL are distinct from their counterparts seen in HIV-1 seronegative patients. About half of all cases of ARLS are associated with a gamma herpesvirus, Epstein–Barr virus (EBV) or human herpesvirus-8 (HHV-8) and AIDS-related KS is far more aggressive than the classical variety of the disease. Several other types of tumors occur with increased frequency in AIDS patients including leiomyosarcoma in children, squamous cell carcinoma of the conjunctiva and multi-centric Castleman’s disease. It is likely that as the epidemic expands and AIDS becomes more of a chronic condition the spectrum of HIV-associated cancer will also evolve.


Human Papilloma Virus Primary Central Nervous System Lymphoma Human Papilloma Virus Infection Human Papilloma Virus Vaccine Primary Effusion Lymphoma 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.



This publication was made possible, in part, by support from the following NIH grants: PHS awards CA70058 and CA82274 to WH and CA76958, NCRR COBRE grant RR15635 and INBRE grant P20 RR016469 to CW.


  1. Aaltonen, L.M., Cajanus, S., Back, L., Nieminen, P., Paavonen, J., Ranki, A. (2005) Extralaryngeal HPV infections in male patients with adult-onset laryngeal papillomatosis. Eur. Arch. Otorhinolaryngol. 262, 708–712.PubMedGoogle Scholar
  2. Ahdieh, L., Klein, R.S., Burk, R., Cu-Uvin, S., Schuman, P., Duerr, A., Safaeian, M., Astemborski, J., Daniel, R., Shah, K. (2001) Prevalence, incidence, and type-specific persistence of human papillomavirus in human immunodeficiency virus (HIV)-positive and HIV-negative women. J. Infect. Dis. 184, 682–690.PubMedGoogle Scholar
  3. Ahdieh-Grant, L., Li, R., Levine, A.M., Massad, L.S., Strickler, H.D., Minkoff, H., Moxley, M., Palefsky, J., Sacks, H., Burk, R.D., Gange, S. J. (2004) Highly active antiretroviral therapy and cervical squamous intraepithelial lesions in human immunodeficiency virus-positive women. J. Natl. Cancer Inst. 96, 1070–1076.PubMedGoogle Scholar
  4. Ambinder, R.F. (2001) Epstein-Barr virus associated lymphoproliferations in the AIDS setting. Eur. J. Cancer 37, 1209–1216.PubMedGoogle Scholar
  5. Aoki, Y., Yarchoan, R., Wyvill, K., Okamoto, S., Little, R.F., Tosato, G. (2001) Detection of viral interleukin-6 in Kaposi sarcoma-associated herpesvirus-linked disorders. Blood 97, 2173–2176.PubMedGoogle Scholar
  6. Asou, H., Said, J.W., Yang, R., Munker, R., Park, D.J., Kamada, N., Koeffler, H.P. (1998) Mechanisms of growth control of Kaposi's sarcoma-associated herpes virus-associated primary effusion lymphoma cells. Blood 91, 2475–2481.PubMedGoogle Scholar
  7. Barclay, L.R., Buskin, S.E., Kahle, E.M., Aboulafia, D.M. (2007) Clinical and immunologic profile of AIDS-related lymphoma in the era of highly active antiretroviral therapy. Clin. Lymphoma Myeloma 7, 272–279.Google Scholar
  8. Behler, C.M., Kaplan, L.D. (2006) Advances in the management of HIV-related non-Hodgkin lymphoma. Curr. Opin. Oncol. 8, 437–443.Google Scholar
  9. Bellan, C., De Falco, G., Lazzi, S., Leoncini, L. (2003) Pathologic aspects of AIDS malignancies. Oncogene 22, 6639–6645.PubMedGoogle Scholar
  10. Beral, V. (1991) Epidemiology of Kaposi's sarcoma. Cancer Surv. 10, 5–22.PubMedGoogle Scholar
  11. Bociek, R.G. (2005) Adult Burkitt's lymphoma. Clin. Lymphoma. 6, 11–20.PubMedGoogle Scholar
  12. Bosch, F.X., Lorincz, A., Munoz, N., Meijer, C.J., Shah, K.V. (2002) The causal relation between human papillomavirus and cervical cancer. J. Clin. Pathol. 55, 244–265.PubMedGoogle Scholar
  13. Boshoff, C., Weiss, R. (2002) AIDS-related malignancies. Nat. Rev. Cancer 2, 373–382.PubMedGoogle Scholar
  14. Campistol, J.M., Gutierrez-Dalmau, A., Torregrosa, J.V. (2004) Conversion to sirolimus: a successful treatment for posttransplantation Kaposi's sarcoma. Transplantation 77, 760–762.PubMedGoogle Scholar
  15. Carbone, A. (2002) AIDS-related non-Hodgkin's lymphomas: from pathology and molecular pathogenesis to treatment. Hum. Pathol. 33, 392–404.PubMedGoogle Scholar
  16. Carbone, A. (2003) Emerging pathways in the development of AIDS-related lymphomas. Lancet Oncol. 4, 22–29.PubMedGoogle Scholar
  17. Carbone, A., Gloghini, A. (2005) AIDS-related lymphomas: from pathogenesis to pathology. Br. J. Haematol. 130, 662–670.PubMedGoogle Scholar
  18. Carbone, A., Gloghini, A. (2007) HHV-8-associated lymphoma: state-of-the-art review. Acta. Haematol. 117, 129–131.PubMedGoogle Scholar
  19. Carter, K.L., Cahir-McFarland, E., Kieff, E. (2002) Epstein-barr virus-induced changes in B-lymphocyte gene expression. J. Virol. 76, 10427–10436.PubMedGoogle Scholar
  20. Casper, C., Nichols, W.G., Huang, M.L., Corey, L., Wald, A. (2004) Remission of HHV-8 and HIV-associated multicentric Castleman disease with ganciclovir treatment. Blood 103, 1632–1634.PubMedGoogle Scholar
  21. Cates Jr., W., Dallabetta, G. (1999) The staying power of sexually transmitted diseases. Lancet 354 Suppl, SIV62.PubMedGoogle Scholar
  22. Cattaneo, C., Facchetti, F., Re, A., Borlenghi, E., Majorana, A., Bardellini, E., Casari, S., Tucci, A., Conti, G., Rossi, G. (2005) Oral cavity lymphomas in immunocompetent and human immunodeficiency virus infected patients. Leuk. Lymphoma 46, 77–81.PubMedGoogle Scholar
  23. Cesarman, E., Chang, Y., Moore, P.S., Said, J.W., Knowles, D.M. (1995) Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N. Engl. J. Med. 332, 1186–1191.PubMedGoogle Scholar
  24. Cesarman, E., Nador, R.G., Aozasa, K., Delsol, G., Said, J.W., Knowles, D.M. (1996) Kaposi's sarcoma-associated herpesvirus in non-AIDS related lymphomas occurring in body cavities. Am. J. Pathol. 149, 53–57.PubMedGoogle Scholar
  25. Chang, Y., Cesarman, E., Pessin, M.S., Lee, F., Culpepper, J., Knowles, D.M., Moore, P.S. (1994) Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 266, 1865–1869.PubMedGoogle Scholar
  26. Cheah, P.L., Looi, L.M. (1998) Biology and pathological associations of the human papillomaviruses: a review. Malays. J. Pathol. 20, 1–10.Google Scholar
  27. Chiasson, M.A., Ellerbrock, T.V., Bush, T.J., Sun, X.W., Wright Jr., T.C. (1997) Increased prevalence of vulvovaginal condyloma and vulvar intraepithelial neoplasia in women infected with the human immunodeficiency virus. Obstet. Gynecol. 89, 690–694.PubMedGoogle Scholar
  28. Cingolani, A., De Luca, A., Larocca, L.M., Ammassari, A., Scerrati, M., Antinori, A., Ortona, L. (1998) Minimally invasive diagnosis of acquired immunodeficiency syndrome-related primary central nervous system lymphoma. J. Natl. Cancer Inst. 90, 364–369.PubMedGoogle Scholar
  29. Cioc, A.M., Allen, C., Kalmar, J.R., Suster, S., Baiocchi, R., Nuovo, G.J. (2004) Oral plasmablastic lymphomas in AIDS patients are associated with human herpesvirus 8. Am. J. Surg. Pathol. 28, 41–46.PubMedGoogle Scholar
  30. Clarke, J., Terry, R.M., Lacey, C.J. (1991) A study to estimate the prevalence of upper respiratory tract papillomatosis in patients with genital warts. Int. J. STD AIDS 2, 114–115.PubMedGoogle Scholar
  31. Corbellino, M., Poirel, L., Aubin, J.T., Paulli, M., Magrini, U., Bestetti, G., Galli, M., Parravicini, C. (1996) The role of human herpesvirus 8 and Epstein-Barr virus in the pathogenesis of giant lymph node hyperplasia (Castleman's disease). Clin. Infect. Dis. 22, 1120–1121.PubMedGoogle Scholar
  32. Corbellino, M., Bestetti, G., Scalamogna, C., Calattini, S., Galazzi, M., Meroni, L., Manganaro, D., Fasan, M., Moroni, M., Galli, M., Parravicini, C. (2001) Long-term remission of Kaposi sarcoma-associated herpesvirus-related multicentric Castleman disease with anti-CD20 monoclonal antibody therapy. Blood 98, 3473–3475.PubMedGoogle Scholar
  33. de Villiers, E.M., Weidauer, H., Le, J.Y., Neumann, C., zur Hausen, H. (1986) [Papilloma viruses in benign and malignant tumors of the mouth and upper respiratory tract]. Laryngol. Rhinol. Otol. 65, 177–179.Google Scholar
  34. Dezube, B.J. (2000) Acquired immunodeficiency syndrome-related Kaposi's sarcoma: clinical features, staging, and treatment. Semin. Oncol. 27, 424–430.PubMedGoogle Scholar
  35. Duerr, A., Sierra, M.F., Feldman, J., Clarke, L.M., Ehrlich, I., DeHovitz, J. (1997) Immune compromise and prevalence of Candida vulvovaginitis in human immunodeficiency virus-infected women. Obstet. Gynecol. 90, 252–256.PubMedGoogle Scholar
  36. Durante, A.J., Williams, A.B., Da Costa, M., Darragh, T.M., Khoshnood, K., Palefsky, J.M. (2003) Incidence of anal cytological abnormalities in a cohort of human immunodeficiency virus-infected women. Cancer Epidemiol. Biomarkers Prev. 12, 638–642.PubMedGoogle Scholar
  37. Edelman, D.C. (2005) Human herpesvirus 8 – a novel human pathogen. Virol. J. 2, 78.PubMedGoogle Scholar
  38. Eliopoulos, A.G., Dawson, C.W., Mosialos, G., Floettmann, J.E., Rowe, M., Armitage, R.J., Dawson, J., Zapata, J.M., Kerr, D.J., Wakelam, M.J., Reed, J.C., Kieff, E., Young, L.S. (1996) CD40-induced growth inhibition in epithelial cells is mimicked by Epstein-Barr Virus-encoded LMP1: involvement of TRAF3 as a common mediator. Oncogene 13, 2243–2254.PubMedGoogle Scholar
  39. Ellerbrock, T.V., Chiasson, M.A., Bush, T.J., Sun, X.W., Sawo, D., Brudney, K., Wright Jr., T.C. (2000) Incidence of cervical squamous intraepithelial lesions in HIV-infected women. JAMA 283, 1031–1037.PubMedGoogle Scholar
  40. El-Mofty, S.K., Lu, D.W. (2003) Prevalence of human papillomavirus type 16 DNA in squamous cell carcinoma of the palatine tonsil, and not the oral cavity, in young patients: a distinct clinicopathologic and molecular disease entity. Am. J. Surg. Pathol. 27, 1463–1470.PubMedGoogle Scholar
  41. Engels, E.A. (2007) Infectious agents as causes of non-Hodgkin lymphoma. Cancer Epidemiol. Biomarkers Prev. 16, 401–404.Google Scholar
  42. Epeldegui, M., Hung, Y.P., McQuay, A., Ambinder, R.F., Martinez-Maza, O. (2007) Infection of human B cells with Epstein-Barr virus results in the expression of somatic hypermutation-inducing molecules and in the accrual of oncogene mutations. Mol. Immunol. 44, 934–942.PubMedGoogle Scholar
  43. Fakhry, C., Gillison, M.L. (2006) Clinical implications of human papillomavirus in head and neck cancers. J. Clin. Oncol. 24, 2606–2611.PubMedGoogle Scholar
  44. Feng, W.H., Hong, G., Delecluse, H.J., Kenney, S.C. (2004) Lytic induction therapy for Epstein-Barr virus-positive B-cell lymphomas. J. Virol. 78, 1893–1902.PubMedGoogle Scholar
  45. Franceschi, S., Geddes, M. (1995) Epidemiology of classic Kaposi's sarcoma, with special reference to mediterranean population. Tumori 81, 308–314.PubMedGoogle Scholar
  46. Franceschi, S., Dal Maso, L., Arniani, S., Crosignani, P., Vercelli, M., Simonato, L., Falcini, F., Zanetti, R., Barchielli, A., Serraino, D., Rezza, G. (1998) Risk of cancer other than Kaposi's sarcoma and non-Hodgkin's lymphoma in persons with AIDS in Italy. Cancer and AIDS Registry Linkage Study. Br. J. Cancer 78, 966–970.PubMedGoogle Scholar
  47. Friedman-Kien, A.E. (1981) Disseminated Kaposi's sarcoma syndrome in young homosexual men. J. Am. Acad. Dermatol. 5, 468–471.PubMedGoogle Scholar
  48. Gao S.J., Kingsley, L., Li, M., Zheng, W., Parravicini, C., Ziegler, J., Newton, R., Rinaldo, C.R., Saah, A., Phair, J., Detels, R., Chang, Y., Moore, P.S. (1996) KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma. Nat. Med. 2, 925–928.PubMedGoogle Scholar
  49. Gasser, O., Bihl, F.K., Wolbers, M., Loggi, E., Steffen, I., Hirsch, H.H., Gunthard, H.F., Walker, B.D., Brander, C., Battegay, M., Hess, C.; for the Swiss HIV Cohort Study. (2007) HIV Patients Developing Primary CNS Lymphoma Lack EBV-Specific CD4(+) T Cell Function Irrespective of Absolute CD4(+) T Cell Counts. PLoS Med. 4, e96.PubMedGoogle Scholar
  50. Ghosh, S.K., Wood, C., Boise, L.H., Mian, A.M., Deyev, V.V., Feuer, G., Toomey, N.L., Shank, N.C., Cabral, L., Barber, G.N., Harrington Jr., W.J. (2003) Potentiation of TRAIL-induced apoptosis in primary effusion lymphoma through azidothymidine-mediated inhibition of NF-kappa B. Blood 101, 2321–2327.PubMedGoogle Scholar
  51. Gill, P.S., Tsai, Y.C., Rao, A.P., Spruck, C.H., Zheng, T., Harrington, W.A., Cheung, T., Nathwani, B., Jones, P.A. (1998) Evidence for multiclonality in multicentric Kaposi's sarcoma. Proc. Natl. Acad. Sci. U.S.A. 95, 8257–8261.Google Scholar
  52. Gillison, M.L., Koch, W.M., Capone, R.B., Spafford, M., Westra, W.H., Wu, L., Zahurak, M.L., Daniel, R.W., Viglione, M., Symer, D.E., Shah, K.V., Sidransky, D. (2000) Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J. Natl. Cancer Inst. 92, 709–720.PubMedGoogle Scholar
  53. Gloeckler Ries, L.A., Reichman, M.E., Lewis, D.R., Hankey, B.F., Edwards, B.K. (2003) Cancer survival and incidence from the Surveillance, Epidemiology, and End Results (SEER) program. Oncologist 8, 541–552.PubMedGoogle Scholar
  54. Hankey, B.F., Ries, L.A., Edwards, B.K. (1999) The surveillance, epidemiology, and end results program: a national resource. Cancer Epidemiol. Biomarkers Prev. 8, 1117–1121.PubMedGoogle Scholar
  55. He, J., Bhat, G., Kankasa, C., Chintu, C., Mitchell, C., Duan, W., Wood, C. (1998) Seroprevalence of human herpesvirus 8 among Zambian women of childbearing age without Kaposi's sarcoma (KS) and mother-child pairs with KS. J. Infect. Dis. 178, 1787–1790.PubMedGoogle Scholar
  56. Heard, I., Schmitz, V., Costagliola, D., Orth, G., Kazatchkine, M.D. (1998) Early regression of cervical lesions in HIV-seropositive women receiving highly active antiretroviral therapy. AIDS 12, 1459–1464.PubMedGoogle Scholar
  57. Heard, I., Tassie, J.M., Schmitz, V., Mandelbrot, L., Kazatchkine, M.D., Orth, G. (2000) Increased risk of cervical disease among human immunodeficiency virus-infected women with severe immunosuppression and high human papillomavirus load(1). Obstet. Gynecol. 96, 403–409.Google Scholar
  58. Hillemanns, P., Ellerbrock, T.V., McPhillips, S., Dole, P., Alperstein, S., Johnson, D., Sun, X.W., Chiasson, M.A., Wright Jr., T.C. (1996) Prevalence of anal human papillomavirus infection and anal cytologic abnormalities in HIV-seropositive women. AIDS 10, 1641–1647.PubMedGoogle Scholar
  59. Hoffmann, C., Tabrizian, S., Wolf, E., Eggers, C., Stoehr, A., Plettenberg, A., Buhk, T., Stellbrink, H.J., Horst, H.A., Jager, H., Rosenkranz, T. (2001) Survival of AIDS patients with primary central nervous system lymphoma is dramatically improved by HAART-induced immune recovery. AIDS 15, 2119–2127PubMedGoogle Scholar
  60. Horenstein, M.G., Nador, R.G., Chadburn, A., Hyjek, E.M., Inghirami, G., Knowles, D.M., Cesarman, E. (1997) Epstein-Barr virus latent gene expression in primary effusion lymphomas containing Kaposi's sarcoma-associated herpesvirus/human herpesvirus-8. Blood 90, 1186–1191.PubMedGoogle Scholar
  61. Iscovich, J., Boffetta, P., Franceschi, S., Azizi, E., Sarid, R. (2000) Classic kaposi sarcoma: epidemiology and risk factors. Cancer 88, 500–517.PubMedGoogle Scholar
  62. Jones, J.L., Hanson, D.L., Dworkin, M.S., Jaffe, H.W. (2000) Incidence and trends in Kaposi's sarcoma in the era of effective antiretroviral therapy. J. Acquir. Immune Defic. Syndr. 24, 270–274.PubMedGoogle Scholar
  63. Kaplan, L.D., Lee, J.Y., Ambinder, R.F., Sparano, J.A., Cesarman, E., Chadburn, A., Levine, A.M., Scadden, D.T. (2005) Rituximab does not improve clinical outcome in a randomized phase 3 trial of CHOP with or without rituximab in patients with HIV-associated non-Hodgkin lymphoma: AIDS-Malignancies Consortium Trial 010. Blood 106, 1538–1543.PubMedGoogle Scholar
  64. Kaposi, M. (1872) Idiopathisches multiples pigmentsarkon der Haut. Arch. Dermatol. Syphilis 4, 265–273.Google Scholar
  65. Katz, M.H., Hessol, N.A., Buchbinder, S.P., Hirozawa, A., O’Malley, P., Holmberg, S.D. (1994) Temporal trends of opportunistic infections and malignancies in homosexual men with AIDS. J. Infect. Dis. 170, 198–202.PubMedGoogle Scholar
  66. Keller, S.A., Hernandez-Hopkins, D., Vider, J., Ponomarev, V., Hyjek, E., Schattner, E.J., Cesarman, E. (2006) NF-kappaB is essential for the progression of KSHV- and EBV-infected lymphomas in vivo. Blood 107, 3295–3302.PubMedGoogle Scholar
  67. Kelly, G., Bell, A., Rickinson, A. (2002) Epstein-Barr virus-associated Burkitt lymphomagenesis selects for downregulation of the nuclear antigen EBNA2. Nat. Med. 8, 1098–1104PubMedGoogle Scholar
  68. Kelly, G.L., Milner, A.E., Tierney, R.J., Croom-Carter, D.S., Altmann, M., Hammerschmidt, W., Bell. A.I., Rickinson, A.B. (2005) Epstein-Barr virus nuclear antigen 2 (EBNA2) gene deletion is consistently linked with EBNA3A, -3B, and -3C expression in Burkitt's lymphoma cells and with increased resistance to apoptosis. J. Virol. 79, 10709–10717.PubMedGoogle Scholar
  69. Knowles, D.M. (2001) Biology of non-Hodgkin's lymphoma. Cancer Treat. Res. 104, 149–200.PubMedGoogle Scholar
  70. Koutsky, L. (1997) Epidemiology of genital human papillomavirus infection. Am. J. Med. 102, 3–8.PubMedGoogle Scholar
  71. Krown, S.E. (1998) Clinical overview: issues in Kaposi's sarcoma therapeutics. J. Natl. Cancer. Inst. Monogr. 23, 59–63.PubMedGoogle Scholar
  72. Krown, S.E. (1998) Interferon-alpha: evolving therapy for AIDS-associated Kaposi's sarcoma. J. Interferon Cytokine Res. 18, 209–214.PubMedGoogle Scholar
  73. Kurokawa, M., Ghosh, S.K., Ramos, J.C., Mian, A.M., Toomey, N.L., Cabral, L., Whitby, D., Barber, G.N., Dittmer, D.P., Harrington Jr., W.J. (2005) Azidothymidine inhibits NF-kappaB and induces Epstein-Barr virus gene expression in Burkitt lymphoma. Blood 106, 235–240.PubMedGoogle Scholar
  74. Levine, A.M. (2002) Challenges in the management of Burkitt's lymphoma. Clin. Lymphoma 3 Suppl 1, S19–S25.PubMedGoogle Scholar
  75. Li, J.J., Huang, Y.Q., Cockerell, C.J., Friedman-Kien, A.E. (1996) Localization of human herpes-like virus type 8 in vascular endothelial cells and perivascular spindle-shaped cells of Kaposi's sarcoma lesions by in situ hybridization. Am. J. Pathol. 148, 1741–1748.PubMedGoogle Scholar
  76. Lillo, F.B., Ferrari, D., Veglia, F., Origoni, M., Grasso, M.A., Lodini, S., Mastrorilli, E., Taccagni, G., Lazzarin, A., Uberti-Foppa, C. (2001) Human papillomavirus infection and associated cervical disease in human immunodeficiency virus-infected women: effect of highly active antiretroviral therapy. J. Infect. Dis. 184, 547–551.PubMedGoogle Scholar
  77. Lim ST, Levine AM. (2005) Recent advances in acquired immunodeficiency syndrome (AIDS)-related lymphoma. CA Cancer J. Clin. 55, 229–241; 60–61, 64.PubMedGoogle Scholar
  78. Lim, S.T., Karim, R., Nathwani, B.N., Tulpule, A., Espina, B., Levine, A.M. (2005) AIDS-related Burkitt's lymphoma versus diffuse large-cell lymphoma in the pre-highly active antiretroviral therapy (HAART) and HAART eras: significant differences in survival with standard chemotherapy. J. Clin. Oncol. 23, 4430–4438.PubMedGoogle Scholar
  79. Little, R.F., Pittaluga, S., Grant, N., Steinberg, S.M., Kavlick, M.F., Mitsuya, H., Franchini, G., Gutierrez, M., Raffeld, M., Jaffe, E.S., Shearer, G., Yarchoan, R., Wilson, W.H. (2003) Highly effective treatment of acquired immunodeficiency syndrome-related lymphoma with dose-adjusted EPOCH: impact of antiretroviral therapy suspension and tumor biology. Blood 101, 4653–4659.PubMedGoogle Scholar
  80. Lopez Amado, M., Castro Lareo, I., Lozano Ramirez, A., Caballero Torcuato, L. (1996) Epidemiology of otorhinolaryngological squamous cell papillomas in a Spanish subpopulation during a 20 year period. Rev. Laryngol. Otol. Rhinol. 117, 105–110.Google Scholar
  81. Marcelin, A.G., Aaron, L., Mateus, C., Gyan, E., Gorin, I., Viard, J.P., Calvez, V., Dupin, N. (2003) Rituximab therapy for HIV-associated Castleman disease. Blood 102, 2786–2788.PubMedGoogle Scholar
  82. Massad, L.S., Riester, K.A., Anastos, K.M., Fruchter, R.G., Palefsky, J.M., Burk, R.D., Burns, D., Greenblatt, R.M., Muderspach, L.I., Miotti, P. (1999) Prevalence and predictors of squamous cell abnormalities in Papanicolaou smears from women infected with HIV-1. Women's Interagency HIV Study Group. J. Acquir. Immune. Defic. Syndr. 21, 33–41.PubMedGoogle Scholar
  83. Massad, L.S., Ahdieh, L., Benning, L., Minkoff, H., Greenblatt, R.M., Watts, H., Miotti, P., Anastos, K., Moxley, M., Muderspach, L.I., Melnick, S. (2001). Evolution of cervical abnormalities among women with HIV-1: evidence from surveillance cytology in the women's interagency HIV study. J. Acquir. Immune. Defic. Syndr. 27, 432–442.PubMedGoogle Scholar
  84. Milde-Langosch, K.M., Loning, T., Meichsner, M., Henke, R.P. (1989) [HPV infections in tumors of the upper respiratory and digestive tract. In situ hybridization and dot-blot hybridization with biotinylated DNA probes]. Acta Histochem. Suppl. 37, 103–108.PubMedGoogle Scholar
  85. Minkoff, H.L., Eisenberger-Matityahu, D., Feldman, J., Burk, R., Clarke, L. (1999). Prevalence and incidence of gynecologic disorders among women infected with human immunodeficiency virus. Am. J. Obstet. Gynecol. 180, 824–836.PubMedGoogle Scholar
  86. Minkoff, H., Ahdieh, L., Massad, L.S., Anastos, K., Watts, D.H., Melnick, S., Muderspach, L., Burk, R., Palefsky, J. (2001) The effect of highly active antiretroviral therapy on cervical cytologic changes associated with oncogenic HPV among HIV-infected women. AIDS 15, 2157–2164.PubMedGoogle Scholar
  87. Moses, A.V., Jarvis, M.A., Raggo, C., Bell, Y.C., Ruhl, R., Luukkonen, B.G., Griffith, D.J., Wait, C.L., Druker, B.J., Heinrich, M.C., Nelson, J.A., Fruh, K. (2002) Kaposi's sarcoma-associated herpesvirus-induced upregulation of the c-kit proto-oncogene, as identified by gene expression profiling, is essential for the transformation of endothelial cells. J. Virol. 76, 8383–8399.PubMedGoogle Scholar
  88. Nador, R.G., Chadburn, A., Gundappa, G., Cesarman, E., Said, J.W., Knowles, D.M. (2003) Human immunodeficiency virus (HIV)-associated polymorphic lymphoproliferative disorders. Am. J. Surg. Pathol. 27, 293–302.PubMedGoogle Scholar
  89. Navarro, W.H., Kaplan, L.D. (2006) AIDS-related lymphoproliferative disease. Blood 107, 13–20.PubMedGoogle Scholar
  90. Newell, M.E., Hoy, J.F., Cooper, S.G., DeGraaff, B., Grulich, A.E., Bryant, M., Millar, J.L., Brew, B.J., Quinn, D.I. (2004) Human immunodeficiency virus-related primary central nervous system lymphoma: factors influencing survival in 111 patients. Cancer 100, 2627–2636.PubMedGoogle Scholar
  91. Newton, R., Ziegler, J., Ateenyi-Agaba, C., Bousarghin, L., Casabonne, D., Beral, V., Mbidde, E., Carpenter, L., Reeves, G., Parkin, D.M., Wabinga, H., Mbulaiteye, S., Jaffe, H., Bourboulia, D., Boshoff, C., Touze, A., Coursaget, P. (2002) The epidemiology of conjunctival squamous cell carcinoma in Uganda. Br. J. Cancer 87, 301–308.PubMedGoogle Scholar
  92. Ocio, E.M., Sanchez-Guijo, F.M., Diez-Campelo, M., Castilla, C., Blanco, O.J., Caballero, D., San Miguel, J.F. (2005) Efficacy of rituximab in an aggressive form of multicentric Castleman disease associated with immune phenomena. Am. J. Hematol. 78, 302–305.PubMedGoogle Scholar
  93. Oksenhendler, E., Carcelain, G., Aoki, Y., Boulanger, E., Maillard, A., Clauvel, J.P., Agbalika, F. (2000) High levels of human herpesvirus 8 viral load, human interleukin-6, interleukin-10, and C reactive protein correlate with exacerbation of multicentric castleman disease in HIV-infected patients. Blood 96, 2069–2073.PubMedGoogle Scholar
  94. Oksenhendler, E., Boulanger, E., Galicier, L., Du, M.Q., Dupin, N., Diss, T.C., Hamoudi, R., Daniel, M.T., Agbalika, F., Boshoff, C., Clauvel, J.P., Isaacson, P.G., Meignin, V. (2002) High incidence of Kaposi sarcoma-associated herpesvirus-related non-Hodgkin lymphoma in patients with HIV infection and multicentric Castleman disease. Blood 99, 2331–2336.PubMedGoogle Scholar
  95. Olsen, S.J., Chang, Y., Moore, P.S., Biggar, R.J., Melbye, M. (1998) Increasing Kaposi's sarcoma-associated herpesvirus seroprevalence with age in a highly Kaposi's sarcoma endemic region, Zambia in 1985. AIDS 12, 1921–1925.PubMedGoogle Scholar
  96. Palefsky, J.M., Barrasso, R. (1996) HPV infection and disease in men. Obstet. Gynecol. Clin. North Am. 23, 895–916.PubMedGoogle Scholar
  97. Palefsky, J.M. (2003) Cervical human papillomavirus infection and cervical intraepithelial neoplasia in women positive for human immunodeficiency virus in the era of highly active antiretroviral therapy. Curr. Opin. Oncol. 15, 382–388.PubMedGoogle Scholar
  98. Pellett, P.E., Wright, D.J., Engels, E.A., Ablashi, D.V., Dollard, S.C., Forghani, B., Glynn, S.A., Goedert, J.J., Jenkins, F.J., Lee, T.H., Neipel, F., Todd, D.S., Whitby, D., Nemo, G.J., Busch, M.P.; Retrovirus Epidemiology Donor Study. (2003) Multicenter comparison of serologic assays and estimation of human herpesvirus 8 seroprevalence among US blood donors. Transfusion 43, 1260–1268.PubMedGoogle Scholar
  99. Petre, C.E., Sin, S.H., Dittmer, D.P. (2007) Functional p53 signaling in Kaposi's sarcoma-associated herpesvirus lymphomas: implications for therapy. J. Virol. 81, 1912–1922.PubMedGoogle Scholar
  100. Phan, R.T., Dalla-Favera, R. (2004) The BCL6 proto-oncogene suppresses p53 expression in germinal-centre B cells. Nature 432, 635–639.PubMedGoogle Scholar
  101. Piketty, C., Darragh, T.M., Heard, I., Da Costa, M., Bruneval, P., Kazatchkine, M.D., Palefsky, J.M. (2004) High prevalence of anal squamous intraepithelial lesions in HIV-positive men despite the use of highly active antiretroviral therapy. Sex. Transm. Dis. 31, 96–99.PubMedGoogle Scholar
  102. Piketty, C., Darragh, T.M., Da Costa, M., Bruneval, P., Heard, I., Kazatchkine, M.D., Palefsky, J.M. (2003) High prevalence of anal human papillomavirus infection and anal cancer precursors among HIV-infected persons in the absence of anal intercourse. Ann. Intern. Med. 138, 453–459.PubMedGoogle Scholar
  103. Rabkin, C.S., Testa, M.A., Huang, J., Von Roenn, J.H. (1999) Kaposi's sarcoma and non-Hodgkin's lymphoma incidence trends in AIDS Clinical Trial Group study participants. J. Acquir. Immune Defic. Syndr. 21 Suppl 1, S31–S33.PubMedGoogle Scholar
  104. Raez, L., Cabral. L., Cai, J.P., Landy, H., Sfakianakis, G., Byrne Jr., G.E., Hurley, J., Scerpella, E., Jayaweera, D., Harrington Jr., W.J. (1999) Treatment of AIDS-related primary central nervous system lymphoma with zidovudine, ganciclovir, and interleukin 2. AIDS Res. Hum. Retroviruses 15, 713–719.PubMedGoogle Scholar
  105. Ratner, L., Lee, J., Tang, S., Redden, D., Hamzeh, F., Herndier, B., Scadden, D., Kaplan, L., Ambinder, R., Levine, A., Harrington, W., Grochow, L., Flexner, C., Tan, B., Straus, D.; AIDS Malignancy Consortium. (2001) Chemotherapy for human immunodeficiency virus-associated non-Hodgkin's lymphoma in combination with highly active antiretroviral therapy. J. Clin. Oncol. 19, 2171–2178.PubMedGoogle Scholar
  106. Re, A., Cattaneo, C., Michieli, M., Casari, S., Spina, M., Rupolo, M., Allione, B., Nosari, A., Schiantarelli, C., Vigano, M., Izzi, I., Ferremi, P., Lanfranchi, A., Mazzuccato, M., Carosi, G., Tirelli, U., Rossi, G. (2003) High-dose therapy and autologous peripheral-blood stem-cell transplantation as salvage treatment for HIV-associated lymphoma in patients receiving highly active antiretroviral therapy. J. Clin. Oncol. 21, 4423–4427.PubMedGoogle Scholar
  107. Roizman, B., Desrosiers, R.C., Fleckenstein, B., Lopez, C., Minson, A.C., Studdert, M.J. (1992) The family Herpesviridae: An update. Arch. Virol. 123, 425–449.Google Scholar
  108. Rooney, C.M., Roskrow, M.A., Smith, C.A., Brenner, M.K., Heslop, H.E. (1998) Immunotherapy for Epstein-Barr virus-associated cancers. J. Natl. Cancer. Inst. Monogr. 89–93.Google Scholar
  109. Roychowdhury, S., Peng, R., Baiocchi, R.A., Bhatt, D., Vourganti, S., Grecula, J., Gupta, N., Eisenbeis, C.F., Nuovo, G.J., Yang, W., Schmalbrock, P., Ferketich, A., Moeschberger, M., Porcu, P., Barth, R.F., Caligiuri, M.A. (2003) Experimental treatment of Epstein-Barr virus-associated primary central nervous system lymphoma. Cancer Res. 63, 965–971.PubMedGoogle Scholar
  110. Sarid, R., Klepfish, A., Schattner, A. (2002) Virology, pathogenetic mechanisms, and associated diseases of Kaposi sarcoma-associated herpesvirus (human herpesvirus 8). Mayo Clin. Proc. 77, 941–949.Google Scholar
  111. Scadden, D.T. (2003) AIDS-related malignancies. Annu. Rev. Med. 54, 285–303.PubMedGoogle Scholar
  112. Schulz, T.F. (2000) KSHV (HHV8) infection. J. Infect. 41, 125–129.PubMedGoogle Scholar
  113. Schuman, P., Ohmit, S.E., Klein, R.S., Duerr, A., Cu-Uvin, S., Jamieson, D.J., Anderson, J., Shah, K.V. (2003) Longitudinal study of cervical squamous intraepithelial lesions in human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women. J. Infect. Dis. 188, 128–136.PubMedGoogle Scholar
  114. Serraino, D. (1999) The spectrum of AIDS-associated cancers in Africa. AIDS 13, 2589–2590.PubMedGoogle Scholar
  115. Silverberg, M.J., Ahdieh, L., Munoz, A., Anastos, K., Burk, R.D., Cu-Uvin, S., Duerr, A., Greenblatt, R.M., Klein, R.S., Massad, S., Minkoff, H., Muderspach, L., Palefsky, J., Piessens, E., Schuman, P., Watts, H., Shah, K.V. (2002) The impact of HIV infection and immunodeficiency on human papillomavirus type 6 or 11 infection and on genital warts. Sex. Transm. Dis. 29, 427–435.PubMedGoogle Scholar
  116. Sin, S.H., Roy, D., Wang, L., Staudt, M.R., Fakhari, F.D., Patel, D.D., Henry, D., Harrington, Jr., W.J., Damania, B.A., Dittmer, D.P. (2007) Rapamycin is efficacious against primary effusion lymphoma (PEL) cell lines in vivo by inhibiting autocrine signaling. Blood 109, 2165–2173.PubMedGoogle Scholar
  117. Sirera, G., Videla, S., Pinol, M., Canadas, M.P., Llatjos, M., Ballesteros, A.L., Garcia-Cuyas, F., Castella, E., Guerola, R., Tural, C., Rey-Joly, C., Clotet, B. (2006). High prevalence of human papillomavirus infection in the anus, penis and mouth in HIV-positive men. AIDS 20, 1201–1204.PubMedGoogle Scholar
  118. Soni, V., Yasui, T., Cahir-McFarland, E., Kieff, E. (2006) LMP1 transmembrane domain 1 and 2 (TM1-2) FWLY mediates intermolecular interactions with TM3-6 to activate NF-kappaB. J. Virol. 80, 10787–10793.PubMedGoogle Scholar
  119. Stallone, G., Schena, A., Infante, B., Di Paolo, S., Loverre, A., Maggio, G., Ranieri, E., Gesualdo, L., Schena, F.P., Grandaliano, G. (2005) Sirolimus for Kaposi's sarcoma in renal-transplant recipients. N. Engl. J. Med. 352, 1317–1323.PubMedGoogle Scholar
  120. Sun, X. W., J. P. Koulos, J. C. Felix, A. Ferenczy, R. M. Richart, T. W. Park, and T. O. Wright, Jr. 1995. Human papillomavirus testing in primary cervical screening. Lancet 346, 636.PubMedGoogle Scholar
  121. Sun, X.W., Kuhn, L., Ellerbrock, T.V., Chiasson, M.A., Bush, T.J., Wright Jr., T.C. (1997) Human papillomavirus infection in women infected with the human immunodeficiency virus. N. Engl. J. Med. 337, 1343–1349.PubMedGoogle Scholar
  122. Syrjanen, S. (2003) Human papillomavirus infections and oral tumors. Med. Microbiol. Immunol. 192, 123–128.PubMedGoogle Scholar
  123. Syrjanen, S. (2005) Human papillomavirus (HPV) in head and neck cancer. J. Clin. Virol. 32 Suppl 1, S59–S66.PubMedGoogle Scholar
  124. Tam, H.K., Zhang, Z.F., Jacobson, L.P., Margolick, J.B., Chmiel, J.S., Rinaldo, C., Detels, R. (2002) Effect of highly active antiretroviral therapy on survival among HIV-infected men with Kaposi sarcoma or non-Hodgkin lymphoma. Int. J. Cancer 98, 916–922.PubMedGoogle Scholar
  125. Waddell, K.M., Lewallen, S., Lucas, S.B., Atenyi-Agaba, C., Herrington, C.S., Liomba, G. (1996) Carcinoma of the conjunctiva and HIV infection in Uganda and Malawi. Br. J. Ophthalmol. 80, 503–508.Google Scholar
  126. Waggoner, S.E. (2003) Cervical cancer. Lancet 361, 2217–2225.PubMedGoogle Scholar
  127. Walboomers, J.M., Jacobs, M.V., Manos, M.M., Bosch, F.X., Kummer, J.A., Shah, K.V., Snijders, P.J., Peto, J., Meijer, C.J., Munoz, N. (1999) Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J. Pathol. 189, 12–19.PubMedGoogle Scholar
  128. Wang, H.W., Trotter, M.W., Lagos, D., Bourboulia, D., Henderson, S., Makinen, T., Elliman, S., Flanagan, A.M., Alitalo, K., Boshoff, C. (2004) Kaposi sarcoma herpesvirus-induced cellular reprogramming contributes to the lymphatic endothelial gene expression in Kaposi sarcoma. Nat. Genet. 36, 687–693.Google Scholar
  129. Williams, A.B., Darragh, T.M., Vranizan, K., Ochia, C., Moss, A.R., Palefsky, J.M. (1994) Anal and cervical human papillomavirus infection and risk of anal and cervical epithelial abnormalities in human immunodeficiency virus-infected women. Obstet. Gynecol. 83, 205–211.PubMedGoogle Scholar
  130. Yarchoan, R., Tosato, G., Little, R.F. (2005) Therapy insight: AIDS-related malignancies--the influence of antiviral therapy on pathogenesis and management. Nat. Clin. Pract. Oncol. 2, 406–415PubMedGoogle Scholar
  131. Young, L.S., Rickinson, A.B. (2004) Epstein-Barr virus: 40 years on. Nat. Rev. Cancer. 4, 757–768.PubMedGoogle Scholar
  132. Zhang, L., Zhang, J., Lambert, Q., Der, C.J., Del Valle, L., Miklossy, J., Khalili, K., Zhou, Y., Pagano, J.S. (2004) Interferon regulatory factor 7 is associated with Epstein-Barr virus-transformed central nervous system lymphoma and has oncogenic properties. J. Virol. 78, 12987–12995.PubMedGoogle Scholar
  133. Zippin, C., Lum, D. (1993) Study of completeness of the surveillance, epidemiology and end results (SEER) program case ascertainment by hospital size and casefinding source. Health Rep. 5, 87–90.PubMedGoogle Scholar
  134. Zmonarski, S.C., Boratynska, M., Puziewicz-Zmonarska, A., Kazimierczak, K., Klinger, M. (2005) Kaposi's sarcoma in renal transplant recipients. Ann. Transplant. 10, 59–65.PubMedGoogle Scholar
  135. zur Hausen[Q1], H. (1999) Papillomaviruses in human cancers. Proc. Assoc. Am. Physicians 111, 581–587.Google Scholar

Copyright information

© Springer Science + Business Media, LLC 2009

Authors and Affiliations

  • William J. Harrington
  • Charles Wood
    • 1
  • C. Wood
  1. 1.Nebraska Center for Virology and the School of Biological SciencesUniversity of Nebraska-LincolnLincolnUSA

Personalised recommendations